专利检索 ap:("Peter Ordentlich" OR "Joanna Horobin" OR "Martha Jo Whitehouse" OR "Miranda Rees") AND inv:"Miranda Rees" 第 1 页

1.

发明申请
COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER 审中-公开
标题翻译： ERA +配体和HISTONE脱乙酰酶抑制剂治疗癌症的联合

公开(公告)号：US20080242648A1

公开(公告)日：2008-10-02

申请号：US11938130

申请日：2007-11-09

申请人： Peter Ordentlich , Joanna Horobin , Martha Jo Whitehouse , Miranda Rees

发明人： Peter Ordentlich , Joanna Horobin , Martha Jo Whitehouse , Miranda Rees

IPC分类号： A61K31/565 , A61K31/4406 , A61K31/164 , A61P35/00 , A61K31/506

CPC分类号： A61K31/165 , A61K31/335 , A61K31/44 , A61K45/06 , A61K2300/00

摘要： The present embodiments relate to compositions and methods of treatment of cancer. More particularly, the present embodiments relate to the combination of an ERα+ ligand with an HDACi for the treatment of cancer, methods of treating cancer and pharmaceutical compositions for treating cancer.

摘要翻译： 本实施方案涉及治疗癌症的组合物和方法。更具体地，本实施方案涉及ERalpha +配体与用于治疗癌症的HDACi的组合，治疗癌症的方法和用于治疗癌症的药物组合物。